• Top in endocrinology: Type 1 diabetes drug approval; hedonic hunger

    8 days ago - By Healio

    Last week, the FDA announced that it has approved Tzield to delay the onset of type 1 diabetes in adults and children aged 8 years and older with stage 2 type 1 diabetes.
    According to the agency, Tzield injection “may deactivate the immune cells that attack insulin-producing cells, while increasing the proportion of cells that help moderate the immune response.” It was the top story in endocrinology last week.
    Another top story was about new trial data that showed weight loss reduced hedonic hunger and bariatric surgery reduced food cravings. The
    Read more ...